About
Intelligyn is a healthcare technology company that specializes in AI-driven clinical decision support systems, particularly for gynecological diagnostics and ovarian cancer detection. Founded in 2022 by Dr. Elisabeth Epstein and her co-founders, the company aims to enhance diagnostic accuracy and accessibility for healthcare professionals, ensuring expert-level care for women everywhere. Intelligyn has developed an AI-powered platform that assists in the ultrasound assessment of ovarian tumors, accurately distinguishing between benign and malignant cases. This platform integrates seamlessly into clinical workflows, providing real-time decision support to doctors and improving diagnostic confidence. The company also offers online medical services focused on medical image assessment, utilizing deep learning techniques to enhance ovarian cancer detection. Intelligyn is actively seeking partnerships to expand the reach of its innovative diagnostic solutions globally, with plans for market release in 2026.
Technologies
Keywords
Company Information
- Employees5
- Founded2022
Location
Stockholm, Stockholm County, Sweden
